Dose Escalation Trial of WT1-specific Donor-derived T Cells Following T-Cell Depleted Allogeneic Hematopoietic Stem Cell Transplantation for Patients With Relapsed/Refractory Multiple Myeloma
Memorial Sloan Kettering Cancer Center
Memorial Sloan Kettering Cancer Center
Dartmouth-Hitchcock Medical Center
University of Rochester
H. Lee Moffitt Cancer Center and Research Institute
Case Comprehensive Cancer Center
Massachusetts General Hospital
University of Iowa
M.D. Anderson Cancer Center
University of California, San Francisco